Cohort of Patients With Systemic Sclerosis Within the Framework of the RESO Reference Centre
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Bordeaux
About this trial
Systemic sclerosis (SSc) is a rare form of connective tissue disease characterized by vascular involvement and the intensity of fibrosis. The lack of available treatment is largely due to the very fragmented understanding of the pathophysiology of SSc. However, one of the keys to conducting quality research on this disease remains the development of well-documented patient cohorts with reliable biological samples. The main objective of this cohort is to study the natural progression of SSc in a cohort of patients followed over 5 years.
Eligibility criteria
Qualifiers
Patient over 18 years old
Patient with systemic scleroderma according to the ACR/EULAR 2013 criteria, or with a " very early systemic sclerosis " defined by the presence of Raynaud's phenomenon and auto-antibodies in blood sample (ACAN positivity (≥1/160) with anti-Scl70, anti-centromere or anti-ARNPolIII specificity).
Person affiliated or benefiting from a social security scheme.
Free, informed and written consent signed by the participant and the investigator (no later than the day of inclusion and prior to any review required by the research)
Disqualifiers
Pregnant or breastfeeding woman
Patient under guardianship, curatorship or any other legal protection regime
Trial design
Treatments tested in this trial
- Blood samples
- Biopsy
- Bronchoalveolar samples
- Biopsy
Treatment groups
500 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov